Clinical Trial Update: A Study to Learn More About How Well 8 Milligram Aflibercept Works and How Safe it is in Chinese Participants With Diabetic Macular Edema [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluates the efficacy and safety of 8 mg aflibercept in Chinese participants with diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Bayer | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED